Los Angeles-based ⁤Cedars-Sinai has appointed Ravi Thadhani, ⁢MD, ⁢as Executive⁣ Vice President of Clinical Affairs and Chief Medical Officer, effective October 15th. This ⁢leadership change marks a significant step for the health system as it continues to prioritize patient care and medical⁤ innovation.

A⁤ Renowned⁣ Expert in Nephrology and Preeclampsia

Dr. thadhani brings extensive expertise to Cedars-Sinai, recognized internationally as ‍a leader⁤ in the fields of nephrology (kidney disease) and ‍preeclampsia, ⁢a pregnancy complication. In his new role, he will be responsible for overseeing⁣ all aspects of clinical quality and safety, medical affairs, and the establishment of medical practice standards⁣ across the Cedars-Sinai system and its affiliated hospitals.

Returning to Cedars-Sinai After National Leadership Roles

Dr. Thadhani is not new to Cedars-Sinai, having previously served as Vice Dean for Research and Graduate Research Education‍ and Chair of the Biomedical Sciences Department from 2017 to 2019. Following his tenure ‍at Cedars-Sinai, he⁤ held leadership positions at Mass ‍General Brigham in Somerville, Massachusetts, and most recently served⁢ as Executive Vice President for Health Affairs at⁣ Emory University in Atlanta, Georgia, and Executive Director of Emory’s Woodruff Health Sciences Center.

Succession and Continued Commitment to Excellence

Dr. Thadhani succeeds Richard Riggs, MD, who is departing at the end of the year to pursue other ⁤opportunities. This transition ensures ⁤continuity of leadership and a continued focus on delivering exceptional healthcare services to the community. The appointment underscores Cedars-sinai’s commitment to ‍attracting and retaining top medical talent to advance its mission of⁢ improving the health and well-being of its patients.